Beckman Coulter Life Sciences · 12 hours ago
Technician Quality Control - Inspection - 1st Shift
Beckman Coulter Life Sciences, a part of Danaher, is dedicated to making a significant impact in life sciences and biotechnology. The Quality Control Technician (Inspection) is responsible for inspecting incoming materials to ensure compliance with specifications and standards, while also managing non-conformance data and contributing to quality assurance processes.
BiotechnologyLife ScienceManufacturing
Responsibilities
Inspect incoming components/materials in line with pre-defined inspection plans
Use appropriate hand gages and equipment as required for individual part inspections
Enter quality data into the proper database to demonstrate the inspection has been successfully completed
Record non-conformance data in the applicable database and provide feedback to appropriate personnel when required
Electronically transfer material according to its acceptance or rejection status
Qualification
Required
Must have a strong mechanical part inspection background (multiple years experience)
Ability to read and comprehend part prints with at least a basic understanding of GD&T fundamentals
Detail oriented, quality conscious with an aptitude for capturing and maintaining accurate records
Ability to lift, move or carry equipment up to 50 lb
Preferred
Previous experience with a CMM machine would be beneficial (not required)
Benefits
Health care program
Paid time off
Company
Beckman Coulter Life Sciences
Beckman Coulter Life Sciences develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests.
H1B Sponsorship
Beckman Coulter Life Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (34)
2024 (27)
2023 (27)
2022 (38)
2021 (26)
2020 (32)
Funding
Current Stage
Late StageTotal Funding
unknownKey Investors
National Cancer Institute
2025-01-22Grant
Leadership Team
Recent News
synbiobeta.com
2025-11-21
2025-11-19
Research and Markets
2025-11-18
Company data provided by crunchbase